CURI Stock Jumps As Record Q2 2026 Earnings Lift Guidance

CuriosityStream Inc. surged as investors cheered strong subscriber growth, with stocks have been trading up by 26.79 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading CURI

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

CuriosityStream reported record Q2 2026 results with revenue up 22%.
Licensing revenue, including data and code licensing for AI training, grew 48%, helping drive a 73% gross margin.
The company posted net income of $8.9M and adjusted EBITDA of $11.4M for the quarter.
Management raised full-year revenue and EBITDA guidance on the back of strong momentum in licensing.
CuriosityStream continues to return capital via dividends and buybacks while maintaining a debt-free balance sheet.

Quick Financial Overview

CURI has quietly been building a base on the daily chart. Over the past few weeks, CuriosityStream stock has climbed from the mid‑$2.30s to around $2.80, a steady series of higher lows that tells traders real buying has stepped in. That slow grind higher set the stage for this Q2 2026 breakout story.

Intraday, the tape shows why CURI is suddenly on more screens. In premarket and early trading, CuriosityStream traded in the mid‑$3.60s to $3.80s, well above the prior $2.80 close. That kind of gap and hold action is classic earnings‑momentum behavior. Volume and price expanded together, which is exactly what momentum traders want to see.

More Breaking News

Fundamentally, CURI is shifting from “promise” to “proof.” The company generated $71.7M in trailing revenue with a 57.2% gross margin and has turned adjusted EBITDA positive at 8.3% margin. Net income is still a small loss on a trailing basis, but the latest quarter flipped solidly into the black. With an enterprise value near $21.98M and price‑to‑sales around 2.3, traders are watching CURI as a lean, content‑and‑licensing name that is finally backing up its story with real numbers.

Why Traders Are Watching CURI Momentum

CuriosityStream’s Q2 2026 print is the kind of catalyst that can reset a chart. Revenue jumped 22% year over year, but the real story for CURI is mix and leverage. Licensing revenue – including data and code licensing for AI training – exploded 48%. That is high‑margin, scalable money, and it helped push quarterly gross margin to a hefty 73%.

For active traders, that matters more than a one‑time pop. High‑margin licensing means CURI can grow profits faster than sales as it scales. Management used that strength to post $8.9M in net income and $11.4M in adjusted EBITDA, then immediately raised full‑year revenue and EBITDA guidance. When a small‑cap like CuriosityStream raises the bar on itself after a record quarter, short sellers have to rethink their thesis and momentum traders take notice.

The tape is already showing that re‑rating. CURI’s gap from sub‑$3 to the mid‑$3s and above, followed by tight intraday ranges between roughly $3.60 and $3.80, signals strong hands stepping in, not just a one‑candle spike. CuriosityStream also checks several boxes the market is rewarding right now: exposure to AI‑related data licensing, a debt‑free balance sheet, and ongoing capital returns via dividends and buybacks.

Put it together and CURI shifts from a pure streaming content story into a hybrid media‑plus‑AI‑licensing play. That reframes how traders model CuriosityStream’s upside and helps explain why the stock is suddenly trading like a momentum name instead of a forgotten micro‑cap.

Conclusion

For traders, the CuriosityStream setup now sits at the intersection of strong fundamentals and a clean technical trend. CURI has record Q2 2026 earnings, rising margins, and an emerging AI‑licensing angle, all while staying debt‑free and still sending cash out through dividends and buybacks. The balance sheet shows $16.9M in cash at the last report and modest liabilities, giving CuriosityStream room to keep funding content and licensing without heavy dilution or leverage.

That said, CURI is still a small, volatile name with negative returns on assets and equity on a trailing basis, and revenue over the last three years has shrunk before this rebound. Any stumble in licensing growth or AI‑related deals can hit the stock hard. This is exactly the type of name where disciplined traders need a plan: entries, exits, and risk defined before clicking the buy button. As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.” Keeping that in mind can help traders frame whether CURI truly meets their criteria or if they’re forcing a trade.

Tim Sykes loves to remind traders, “Cut losses quickly; small losses are fine, big losses are not.” CURI’s Q2 surge and guidance raise give plenty to study – from the earnings numbers to the price action around $3.50–$3.80. Use CuriosityStream as a live case study in how a beaten‑down ticker can flip the script with one powerful quarter, but treat it as a trading opportunity to research and learn from, not a guarantee of future profits.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!